Risk Factors and Outcomes of Recurrent Pregnancy Loss in Japan

Keiko Morita, Yosuke Ono, Toshiyuki Takeshita, Toshitaka Sugi, Tomoyuki Fujii, Hideto Yamada, Mikiya Nakatsuka, Atsushi Fukui, Shigeru Saito

Research output: Contribution to journalArticle

Abstract

Aim: To clarify the risk factors and pregnancy outcomes for each risk factor of recurrent pregnancy loss (RPL) in Japan. Methods: Using a prospective RPL database collected from 16 facilities in Japan, the prevalence of risk factors for RPL, their treatments and pregnancy outcomes were examined. Results: Of 6663 patients registered in our database, 5708 patients had RPL. All examinations for risk factors were performed for 1340 patients (23.5%). The prevalences of positive antiphospholipid antibodies (aPL), malformation of the uterus, thyroid dysfunction, parental karyotype abnormality, factor XII deficiency, protein S deficiency and unknown risk factors were 8.7%, 7.9%, 9.5%, 3.7%, 7.6%, 4.3% and 65.1%, respectively. Although factor XII deficiency and protein S deficiency are not recognized as risk factors for RPL in general, low-dose aspirin (LDA) or unfractionated heparin + LDA therapy improved live birth rates. In transiently aPL-positive patients, the live birth rate with LDA therapy was similar to that with heparin + LDA. For unknown risk factors of RPL, the live birth rate in normal fetal karyotype in the none treatment group was similar to that in all other treatments group (81.3% vs 86.0%). Of 5708 RPL patients, pregnancy outcomes were known for 2261 patients and 1697 patients (75.1%) had at least one live birth. Conclusion: The risk factors and pregnancy outcomes for each risk factor of RPL are useful for clinicians and patients. Factor XII deficiency and protein S deficiency may be risk factors of RPL.

Original languageEnglish
JournalJournal of Obstetrics and Gynaecology Research
DOIs
Publication statusAccepted/In press - Jan 1 2019

Fingerprint

Pregnancy Outcome
Japan
Pregnancy
Factor XII Deficiency
Protein S Deficiency
Aspirin
Live Birth
Antiphospholipid Antibodies
Birth Rate
Karyotype
Heparin
Databases
Pregnancy Rate
Therapeutics
Uterus
Thyroid Gland

Keywords

  • factor XII deficiency
  • pregnancy outcomes
  • protein S deficiency
  • recurrent pregnancy loss
  • risk factors

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Morita, K., Ono, Y., Takeshita, T., Sugi, T., Fujii, T., Yamada, H., ... Saito, S. (Accepted/In press). Risk Factors and Outcomes of Recurrent Pregnancy Loss in Japan. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.14083

Risk Factors and Outcomes of Recurrent Pregnancy Loss in Japan. / Morita, Keiko; Ono, Yosuke; Takeshita, Toshiyuki; Sugi, Toshitaka; Fujii, Tomoyuki; Yamada, Hideto; Nakatsuka, Mikiya; Fukui, Atsushi; Saito, Shigeru.

In: Journal of Obstetrics and Gynaecology Research, 01.01.2019.

Research output: Contribution to journalArticle

Morita, Keiko ; Ono, Yosuke ; Takeshita, Toshiyuki ; Sugi, Toshitaka ; Fujii, Tomoyuki ; Yamada, Hideto ; Nakatsuka, Mikiya ; Fukui, Atsushi ; Saito, Shigeru. / Risk Factors and Outcomes of Recurrent Pregnancy Loss in Japan. In: Journal of Obstetrics and Gynaecology Research. 2019.
@article{847dc55e297648b8ba1be20948ee066b,
title = "Risk Factors and Outcomes of Recurrent Pregnancy Loss in Japan",
abstract = "Aim: To clarify the risk factors and pregnancy outcomes for each risk factor of recurrent pregnancy loss (RPL) in Japan. Methods: Using a prospective RPL database collected from 16 facilities in Japan, the prevalence of risk factors for RPL, their treatments and pregnancy outcomes were examined. Results: Of 6663 patients registered in our database, 5708 patients had RPL. All examinations for risk factors were performed for 1340 patients (23.5{\%}). The prevalences of positive antiphospholipid antibodies (aPL), malformation of the uterus, thyroid dysfunction, parental karyotype abnormality, factor XII deficiency, protein S deficiency and unknown risk factors were 8.7{\%}, 7.9{\%}, 9.5{\%}, 3.7{\%}, 7.6{\%}, 4.3{\%} and 65.1{\%}, respectively. Although factor XII deficiency and protein S deficiency are not recognized as risk factors for RPL in general, low-dose aspirin (LDA) or unfractionated heparin + LDA therapy improved live birth rates. In transiently aPL-positive patients, the live birth rate with LDA therapy was similar to that with heparin + LDA. For unknown risk factors of RPL, the live birth rate in normal fetal karyotype in the none treatment group was similar to that in all other treatments group (81.3{\%} vs 86.0{\%}). Of 5708 RPL patients, pregnancy outcomes were known for 2261 patients and 1697 patients (75.1{\%}) had at least one live birth. Conclusion: The risk factors and pregnancy outcomes for each risk factor of RPL are useful for clinicians and patients. Factor XII deficiency and protein S deficiency may be risk factors of RPL.",
keywords = "factor XII deficiency, pregnancy outcomes, protein S deficiency, recurrent pregnancy loss, risk factors",
author = "Keiko Morita and Yosuke Ono and Toshiyuki Takeshita and Toshitaka Sugi and Tomoyuki Fujii and Hideto Yamada and Mikiya Nakatsuka and Atsushi Fukui and Shigeru Saito",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/jog.14083",
language = "English",
journal = "Journal of Obstetrics and Gynaecology Research",
issn = "1341-8076",
publisher = "Blackwell Publishing Asia",

}

TY - JOUR

T1 - Risk Factors and Outcomes of Recurrent Pregnancy Loss in Japan

AU - Morita, Keiko

AU - Ono, Yosuke

AU - Takeshita, Toshiyuki

AU - Sugi, Toshitaka

AU - Fujii, Tomoyuki

AU - Yamada, Hideto

AU - Nakatsuka, Mikiya

AU - Fukui, Atsushi

AU - Saito, Shigeru

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Aim: To clarify the risk factors and pregnancy outcomes for each risk factor of recurrent pregnancy loss (RPL) in Japan. Methods: Using a prospective RPL database collected from 16 facilities in Japan, the prevalence of risk factors for RPL, their treatments and pregnancy outcomes were examined. Results: Of 6663 patients registered in our database, 5708 patients had RPL. All examinations for risk factors were performed for 1340 patients (23.5%). The prevalences of positive antiphospholipid antibodies (aPL), malformation of the uterus, thyroid dysfunction, parental karyotype abnormality, factor XII deficiency, protein S deficiency and unknown risk factors were 8.7%, 7.9%, 9.5%, 3.7%, 7.6%, 4.3% and 65.1%, respectively. Although factor XII deficiency and protein S deficiency are not recognized as risk factors for RPL in general, low-dose aspirin (LDA) or unfractionated heparin + LDA therapy improved live birth rates. In transiently aPL-positive patients, the live birth rate with LDA therapy was similar to that with heparin + LDA. For unknown risk factors of RPL, the live birth rate in normal fetal karyotype in the none treatment group was similar to that in all other treatments group (81.3% vs 86.0%). Of 5708 RPL patients, pregnancy outcomes were known for 2261 patients and 1697 patients (75.1%) had at least one live birth. Conclusion: The risk factors and pregnancy outcomes for each risk factor of RPL are useful for clinicians and patients. Factor XII deficiency and protein S deficiency may be risk factors of RPL.

AB - Aim: To clarify the risk factors and pregnancy outcomes for each risk factor of recurrent pregnancy loss (RPL) in Japan. Methods: Using a prospective RPL database collected from 16 facilities in Japan, the prevalence of risk factors for RPL, their treatments and pregnancy outcomes were examined. Results: Of 6663 patients registered in our database, 5708 patients had RPL. All examinations for risk factors were performed for 1340 patients (23.5%). The prevalences of positive antiphospholipid antibodies (aPL), malformation of the uterus, thyroid dysfunction, parental karyotype abnormality, factor XII deficiency, protein S deficiency and unknown risk factors were 8.7%, 7.9%, 9.5%, 3.7%, 7.6%, 4.3% and 65.1%, respectively. Although factor XII deficiency and protein S deficiency are not recognized as risk factors for RPL in general, low-dose aspirin (LDA) or unfractionated heparin + LDA therapy improved live birth rates. In transiently aPL-positive patients, the live birth rate with LDA therapy was similar to that with heparin + LDA. For unknown risk factors of RPL, the live birth rate in normal fetal karyotype in the none treatment group was similar to that in all other treatments group (81.3% vs 86.0%). Of 5708 RPL patients, pregnancy outcomes were known for 2261 patients and 1697 patients (75.1%) had at least one live birth. Conclusion: The risk factors and pregnancy outcomes for each risk factor of RPL are useful for clinicians and patients. Factor XII deficiency and protein S deficiency may be risk factors of RPL.

KW - factor XII deficiency

KW - pregnancy outcomes

KW - protein S deficiency

KW - recurrent pregnancy loss

KW - risk factors

UR - http://www.scopus.com/inward/record.url?scp=85070297908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070297908&partnerID=8YFLogxK

U2 - 10.1111/jog.14083

DO - 10.1111/jog.14083

M3 - Article

C2 - 31397532

AN - SCOPUS:85070297908

JO - Journal of Obstetrics and Gynaecology Research

JF - Journal of Obstetrics and Gynaecology Research

SN - 1341-8076

ER -